Malaria pp 567-576 | Cite as

Vaccination Using Normal Live Sporozoites Under Drug Treatment

  • Laurent RéniaEmail author
  • Anne Charlotte Grüner
  • Marjorie Mauduit
  • Georges Snounou
Part of the Methods in Molecular Biology book series (MIMB, volume 923)


Sterile immunity against malaria has been obtained in mammalian hosts exclusively through vaccination with whole parasite preparations. Induction of complete protection against challenge was obtained using sporozoites attenuated by irradiation or genetic manipulations. It has been demonstrated recently that immunization with normal sporozoites under chloroquine cover confers sterile protection in mice and humans, using substantially fewer parasites and injections than with irradiated sporozoite immunization. Subsequently, it was shown that other drugs can substitute for chloroquine. We describe the immunization protocol using live sporozoites under chloroquine cover, which confers sterile immunity in rodents.

Key words

Malaria Sporozoites Vaccine Parasite Plasmodium Drug 



This work was supported by intramural grants from the Agency for Science, technology, and Research (A*STAR) and Institut National de la Sante et de la Recherche Medicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


  1. 1.
    Epstein JE et al (2007) Malaria vaccines: are we getting closer? Curr Opin Mol Ther 9:12–24PubMedGoogle Scholar
  2. 2.
    Alonso PL et al (2004) Efficacy of the RTS, S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 364:1411–1420PubMedCrossRefGoogle Scholar
  3. 3.
    Alonso PL et al (2005) Duration of protection with RTS, S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. Lancet 366:2012–2018PubMedCrossRefGoogle Scholar
  4. 4.
    Bojang KA et al (2001) Efficacy of RTS, S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet 358:1927–1934PubMedCrossRefGoogle Scholar
  5. 5.
    Snounou G et al (2005) The Plasmodium sporozoite survives RTS, S vaccination. Trends Parasitol 21:456–461PubMedCrossRefGoogle Scholar
  6. 6.
    Hoffman SL et al (2002) Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 185:1155–1164PubMedCrossRefGoogle Scholar
  7. 7.
    Mueller AK et al (2005) Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc Natl Acad Sci USA 102:3022–3027PubMedCrossRefGoogle Scholar
  8. 8.
    Mueller AK et al (2005) Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 433:164–167PubMedCrossRefGoogle Scholar
  9. 9.
    Van Buskirk KM et al (2009) Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc Natl Acad Sci USA 106:13004–13009CrossRefGoogle Scholar
  10. 10.
    Vaughan AM et al (2010) Genetically engineered, attenuated whole-cell vaccine approaches for malaria. Hum Vaccin 6:107–113PubMedCrossRefGoogle Scholar
  11. 11.
    van Schaijk BC et al (2008) Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes. PLoS One 3:e3549PubMedCrossRefGoogle Scholar
  12. 12.
    Renia L et al (2006) Vaccination against malaria with live parasites. Expert Rev Vaccines 5:473–481PubMedCrossRefGoogle Scholar
  13. 13.
    Beaudoin RL et al (1977) Plasmodium berghei: immunization of mice against the ANKA strain using the unaltered sporozoites as antigens. Exp Parasitol 42:1–5PubMedCrossRefGoogle Scholar
  14. 14.
    Orjih AU et al (1982) Comparative studies on the immunogenicity of infective and attenuated sporozoites of Plasmodium berghei. Trans R Soc Trop Med Hyg 76:57–61PubMedCrossRefGoogle Scholar
  15. 15.
    Belnoue E et al (2004) Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J Immunol 172:2487–2495PubMedGoogle Scholar
  16. 16.
    Putrianti ED et al (2009) Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites. J Infect Dis 199:899–903PubMedCrossRefGoogle Scholar
  17. 17.
    Friesen J et al (2011) Induction of antimalaria immunity by pyrimethamine prophylaxis during exposure to sporozoites is curtailed by parasite resistance. Antimicrob Agents Chemother 55:2760–2767PubMedCrossRefGoogle Scholar
  18. 18.
    Culleton RL et al (2011) Strain-specific immunity induced by immunization with pre-erythrocytic stages of Plasmodium chabaudi. Parasite Immunol 33:73–78PubMedCrossRefGoogle Scholar
  19. 19.
    Friesen J et al (2010) Natural immunization against malaria: causal prophylaxis with antibiotics. Sci Transl Med 2:40–49CrossRefGoogle Scholar
  20. 20.
    Roestenberg M et al (2009) Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 361:468–477PubMedCrossRefGoogle Scholar
  21. 21.
    Roestenberg M et al (2011) Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 377:1770–1776PubMedCrossRefGoogle Scholar
  22. 22.
    Mauduit M et al (2010) A minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites. Infect Immun 70:2182–2188CrossRefGoogle Scholar
  23. 23.
    Mauduit M et al (2009) A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites. PLoS One 4:e7717PubMedCrossRefGoogle Scholar
  24. 24.
    Mwakingwe A et al (2009) Noninvasive real-time monitoring of liver-stage development of bioluminescent Plasmodium parasites. J Infect Dis 200:1470–1478PubMedCrossRefGoogle Scholar
  25. 25.
    Ploemen IH et al (2009) Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging. PLoS One 4:e7881PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Laurent Rénia
    • 1
    Email author
  • Anne Charlotte Grüner
    • 1
  • Marjorie Mauduit
    • 1
  • Georges Snounou
    • 2
  1. 1.Singapore Immunology Network, Agency for Science, Technology and Research, BiopolisSingaporeSingapore
  2. 2.Hôpital Pitié-Salpêtrière, Université Paris 6ParisFrance

Personalised recommendations